ADVERTISEMENT
The experimental treatment, currently being tested in laboratory and early clinical studies, targets cancer cells in a way that allows the body’s immune system to recognize and attack tumors more efficiently. According to researchers involved in the project, the therapy appears to trigger a rapid response that can lead to noticeable tumor reduction in a very short period of time.
ADVERTISEMENT